Repare Therapeutics Eulerpool Nyheter

Repare Therapeutics Aksje Nyheter

Repare Therapeutics blir fulgt av mange journalister og investorer over hele verden. De nyeste Repare Therapeutics nyhetene presenterer vi her.

• ·

  Yahoo
  Repare Therapeutics Announces Agreement with the US National Cancer Institute to Advance the Development of Camonsertib
• ·

  Yahoo
  Repare Therapeutics Provides Business and Clinical Update and Reports Third Quarter 2024 Financial Results
• ·

  TipRanks
  Repare Therapeutics Receives Buy Rating Due to Improved Treatment Tolerability and Promising Clinical Outcomes
• ·

  Yahoo
  Repare Therapeutics’ individualised anaemia management trial shows promise
• ·

  TipRanks
  TD Cowen Sticks to Its Buy Rating for Repare Therapeutics (RPTX)
• ·

  Yahoo
  Repare Therapeutics Announces Updated Positive Safety and Tolerability Results from the Phase 1 MYTHIC Clinical Trial
• ·

  Thefly.com
  Repare Therapeutics presents data from Phase 1 MYTHIC clinical trial
• ·

  Yahoo
  RPTX Stock Up as Dosing Begins in Solid Tumor Study for Combo Drug
• ·

  Yahoo
  Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-3467, a Polθ ATPase Inhibitor
• ·

  Thefly.com
  Repare Therapeutics doses first patient in POLAR trial